EMVision Medical Devices (ASX:EMV) said ethics approval was granted for a feasibility, usability, and workflow implementation aeromedical study as well as for a first responder study during acute suspected stroke cases attended by the Melbourne mobile stroke unit for its first responder portable brain scanner device, according to a Tuesday Australian bourse filing.
The aeromedical study is a collaboration of the Royal Flying Doctor Service, South Australia Ambulance Service's emergency retrieval service MedStar, South Australia Health's Rural Support Services, the Royal Adelaide Hospital, and the Australian Stroke Alliance.
The study will look at the device's usability, reliability, functionality, workflow metrics, and other tests as necessary to meet user and international regulatory requirements. It is on track to begin recruitment during the September quarter, with study results expected to be reported in the December quarter.
The mobile stroke unit study will evaluate the use of the first responder device during pre-hospital emergency response to acute suspected stroke patients, while gathering contemporaneous ground-truth CT-scan data. The study is on track to begin during the September quarter.
The firm received a AU$400,000 non-dilutive milestone payment under the Australian Stroke Alliance project agreement for completing the "Telemedicine and Road/Air Integration" milestone.
The company's shares fell past 1% in recent Tuesday trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.